286 related articles for article (PubMed ID: 26702876)
1. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
2. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
[TBL] [Abstract][Full Text] [Related]
3. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
5. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin.
Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y
Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548
[TBL] [Abstract][Full Text] [Related]
6. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
Bai S; Zhang Z; Hou S; Liu X
Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
[TBL] [Abstract][Full Text] [Related]
7. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
8. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
9. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod-induced murine psoriasiform dermatitis.
Takeoka S; Shimizu T; Kamata M; Hau CS; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2020 Feb; 47(2):155-162. PubMed ID: 31762070
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
14. Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-κB expression.
Han L; Sun J; Lu CJ; Zhao RZ; Lu Y; Lin HJ; Wei JA
Int Immunopharmacol; 2017 Mar; 44():226-233. PubMed ID: 28129604
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
16. The vitamin D
Hau CS; Shimizu T; Tada Y; Kamata M; Takeoka S; Shibata S; Mitsui A; Asano Y; Sugaya M; Kadono T; Sato S; Watanabe S
J Dermatol Sci; 2018 Nov; 92(2):117-126. PubMed ID: 30166055
[TBL] [Abstract][Full Text] [Related]
17. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
18. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
19. Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion.
Shao S; Cao T; Jin L; Li B; Fang H; Zhang J; Zhang Y; Hu J; Wang G
J Invest Dermatol; 2016 Jul; 136(7):1418-1428. PubMed ID: 26979478
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pyogenes-induced cutaneous lymphocyte antigen-positive T cell-dependent epidermal cell activation triggers TH17 responses in patients with guttate psoriasis.
Ruiz-Romeu E; Ferran M; Sagristà M; Gómez J; Giménez-Arnau A; Herszenyi K; Hóllo P; Celada A; Pujol R; Santamaria-Babí LF
J Allergy Clin Immunol; 2016 Aug; 138(2):491-499.e6. PubMed ID: 27056267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
